ChemoMetec A/S affirmed earnings guidance for the fiscal year 2022/2023. For the year, based on developments in the third quarter of 2022/23, guidance for financial year 2022/23, as announced in connection with the release of the interim report for 2022/23 on 8 February 2023, is maintained. Accordingly, revenue for 2022/23 is expected in the range of DKK 430 million - DKK 460 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
366.6 DKK | -0.70% | +1.66% | -5.52% |
May. 24 | ChemoMetec A/S Announces CFO Changes | CI |
Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.52% | 928M | |
+75.35% | 12.55B | |
-23.01% | 7.51B | |
+8.35% | 6.74B | |
+14.40% | 5.47B | |
-14.85% | 4.89B | |
+32.74% | 4.74B | |
-25.57% | 3.7B | |
-23.06% | 2.9B | |
+55.06% | 2.49B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023